Definium Therapeutics (DFTX) Net Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | 102.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.45% |
| Dec 31, 2025 | 1,204.15% |
| Sep 30, 2025 | -125.71% |
| Jun 30, 2025 | -437.84% |
| Mar 31, 2025 | -225.04% |
| Dec 31, 2024 | -19.89% |
| Sep 30, 2024 | 6,656.87% |
| Jun 30, 2024 | 26.81% |
| Mar 31, 2024 | 1,297.43% |
| Dec 31, 2023 | -44.53% |
| Sep 30, 2023 | -98.42% |
| Jun 30, 2023 | 13.52% |
| Mar 31, 2023 | 2.18% |
| Dec 31, 2022 | -63.74% |
| Sep 30, 2022 | 405.92% |
| Jun 30, 2022 | -334.07% |
| Mar 31, 2022 | -116.36% |
| Dec 31, 2021 | -112.33% |
| Sep 30, 2021 | -174.11% |
| Jun 30, 2021 | -194.07% |
| Mar 31, 2021 | 476.81% |
| Dec 31, 2020 | 818.60% |